Using DSS-induced colitis in mice, the researchers showed that the administration of CCP and BBR had an impact on suppressing inflammatory conditions in the colon, possibly by regulating the production of SCFAs and related gut bacteria, which promoted the expression of tight junction proteins by epithelial cells and activated IL-22 producing cells via modulating AhR signaling pathway. This evidence concerns the gene AHR and colitis.